[Possible existence of an antiradioprotective effect of catecholamines].
D000818:Animals; D002395:Catecholamines / Q000627:therapeutic use*; D003983:Dibenzylchlorethamine / Q000627:therapeutic use; D004336:Drug Antagonism; D004357:Drug Synergism; D004837:Epinephrine / Q000627:therapeutic use; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000627:therapeutic use; D010656:Phenylephrine / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011833:Radiation Injuries, Experimental / Q000188:drug therapy*; D013566:Sympathomimetics / Q000627:therapeutic use*
D002395:Catecholamines; D013566:Sympathomimetics; D010656:Phenylephrine; D003983:Dibenzylchlorethamine; D011433:Propranolol; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine
O vozmozhnom sushchestvovanii "antiradiozashchitnogo" éffekta katekholaminov.